Therapy & Research
WHAT’S NEW
Having attended the surprisingly few SoCal events over the past few years, it was such a welcome pleasure to see familiar faces co...
For its fifth installment, Psychedelic Science 2025 returned to Denver, offering three days of big ideas, heartfelt community, and...
In part one of a series of articles on ibogaine clinics, researcher Leonard Pickard looks at the history and treatment protocols o...
POPULAR ARTICLES
Synthetic Psychedelics May Soon Replace Your Shrooms
Scientists are engineering microbes that can produce the hallucinogenic ingredient in magic mushrooms...
Read More
DEA vs. Drug Science
How do U.S. Drug Enforcement Administration statements about psilocybin mushrooms stack up against actual science?...
Read More
Can a Company Patent the Basic Components of Psychedelic Therapy?
Compass Pathways, a Peter Thiel-backed psychedelic mental health company, has made patent application claims on aspects of psilocy...
Read More
New Study Shows SSRIs Ineffective Compared to Psychedelics
New Study Shows SSRIs Ineffective vs Psychedelics....
Read More
Let’s Talk About Compass And Psychedelic Capitalism: Interview with Rick Doblin
Rick Doblin of MAPS sits down with Wesley Thoricatha to discuss Compass, for-profit psilocybin, and the emerging landscape of psyc...
Read More
Georgia Lawmakers Talk Next Steps For Psychedelics Research For Military Veterans At Committee Hearing
Georgia lawmakers discussed the therapeutic potential of psychedelics like psilocybin for serious mental health conditions at a he...
Read More